Androgen Receptor Antibody

About the Target

The androgen receptor (AR) is a nuclear receptor and transcription factor that mediates the effects of androgens, primarily testosterone and dihydrotestosterone (DHT), playing a crucial role in male reproductive development, secondary sexual characteristics, and broader physiological processes across multiple organ systems, including muscle, bone, the cardiovascular system, and the central nervous system. Structurally, AR comprises an N-terminal domain, a DNA-binding domain, and a ligand-binding domain, functioning through both genomic pathways, where it regulates gene transcription and non-genomic pathways that activate intracellular signalling cascades. Depending on the literature source, AR may also be discussed as Androgen Receptor.

Reported cellular context includes cytoplasm and nucleus, which can matter when signal is compared across treatments or changing cell states. Following AR across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

AR is commonly interpreted in the context of cancer, endocrinology, and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cytoplasm and nucleus across matched conditions
• changes associated with proliferative state, oncogenic signaling, or treatment response
• responses to hormone-dependent signaling or endocrine feedback context
• signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for AR. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in AR reflect biology rather than handling. When interpreting AR, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep AR trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.